LIN YANG
The Hong Kong Polytechnic University · School of Nursing National Defense Medical Center · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name LIN YANG as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:35 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07787403 · Pilot RCT of PIPE-AI for Prediabetes and Diabetes Self-ManagementThe Hong Kong Polytechnic University · not yet recruiting · Prediabetes / Type 2 Diabetes, Diabetes Mellitus, Type 2, Prediabetes · principal investigator
- N/ANCT07693907 · A Taiwan-Adapted Self-Management Program for Adults With Irritable Bowel SyndromeNational Defense Medical Center, Taiwan · not yet recruiting · Irritable Bowel Syndrome · principal investigator
- Ph2NCT07561463 · Sacituzumab Tirumotecan for Pancreatic CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · not yet recruiting · Pancreatic Ductal Adenocarcinoma (PDAC) · principal investigator
- Ph2NCT06808971 · Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma · principal investigator
- Ph2NCT06789679 · Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT06761846 · Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma · principal investigator
- Ph2NCT06711471 · Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric CancerLIN YANG · recruiting · Gastric Cancer Adenocarcinoma Metastatic · principal investigator
- N/ANCT06417892 · Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Gastric Cancer · principal investigator
- Ph2NCT06405139 · Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Colorectal Cancer · principal investigator
- N/ANCT06211660 · An Edge AI-based AR System for Hand Hygiene Training in Undergraduates of Health Related DisciplinesThe Hong Kong Polytechnic University · unknown · Hand Hygiene · principal investigator
- N/ANCT06034964 · Tislelizumab Combined With Chemotherapy in First-line Treatment of AGCCancer Institute and Hospital, Chinese Academy of Medical Sciences · unknown · Tislelizumab, Chemotherapy, First-line · principal investigator
- N/ANCT05872581 · Education Program of Hand Hygiene for Nursing StudentsThe Hong Kong Polytechnic University · completed · Hand Hygiene · principal investigator
- N/ANCT05452824 · Participating in Tai Chi to Reduce Anxiety and Keep up Physical FunctionAHS Cancer Control Alberta · unknown · Prostate Cancer · principal investigator
- Ph1/Ph2NCT04380103 · A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerChinese Academy of Medical Sciences · unknown · Metastatic Cancer, Colorectal Cancer, Colorectal Adenocarcinoma · principal investigator
- N/ANCT04000113 · Therapeutic Effect of Laser Acupuncture on Insomnia in Perimenopausal WomenTaipei Veterans General Hospital, Taiwan · unknown · Insomnia Type; Sleep Disorder, Perimenopausal Women · principal investigator
- Ph1/Ph2NCT02851589 · Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and LymphomaPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma · principal investigator
- Ph1/Ph2NCT02839954 · CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Hepatocellular Carcinoma, Non-small Cell Lung Cancer, Pancreatic Carcinoma · principal investigator
- Ph1/Ph2NCT02742727 · CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and LymphomaPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell Prolymphocytic Leukemia · principal investigator
- N/ANCT02621684 · Physical Activity Intervention in African American Men After Radical ProstatectomyWashington University School of Medicine · withdrawn · Prostatectomy, Prostate Cancer · principal investigator
- Ph1/Ph2NCT02617134 · CAR-T Cell Immunotherapy in MUC1 Positive Solid TumorPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Malignant Glioma of Brain, Colorectal Carcinoma, Gastric Carcinoma · principal investigator
- Ph1/Ph2NCT02587689 · Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Hepatocellular Carcinoma, Non-small Cell Lung Cancer, Pancreatic Carcinoma · principal investigator
- Ph2NCT02504229 · DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentBeijing Biohealthcare Biotechnology Co.,Ltd · unknown · Gastric Cancer · principal investigator
- Ph2NCT01980810 · First Line Chemotherapy for Advanced CancerChinese Academy of Medical Sciences · terminated · Gastric Cancer · principal investigator
- Ph1/Ph2NCT01542294 · SOX as Adjuvant Chemotherapy for Resectable Gastric CancerChinese Academy of Medical Sciences · unknown · Gastric Cancer · principal investigator
- Ph2NCT01529164 · Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerChinese Academy of Medical Sciences · unknown · Colorectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 26 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in pancreatic cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:35 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.J Hematol Oncol · 2021279 citationsRCR 13.5
- Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer.J Clin Oncol · 202363 citationsRCR 4.8
- Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.Dig Dis Sci · 200848 citationsRCR 1.4
- Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells.Cancer Cell · 202043 citationsRCR 1.8
- Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial.Cancer Chemother Pharmacol · 201823 citationsRCR 0.5
- 10 citationsRCR 0.4